THIS SITE IS INTENDED FOR U.S. RESIDENTS ONLY

THIS SITE IS INTENDED
FOR U.S. RESIDENTS ONLY

FOR U.S. HEALTHCARE
PROFESSIONALS ONLY

FOR U.S. HEALTHCARE PROFESSIONALS ONLY

IPSEN CARES® Patient Support Program Offerings

Visit www.ipsencares.com to learn more about support 
for eligible TAZVERIK® patients

TAZVERIK-Summary-Brochure

IPSEN CARES® Flashcard

Information on how IPSEN CARES can provide support to patients who have been prescribed TAZVERIK.

DOWNLOAD
Patient Assistance Program (PAP)

Patient Assistance
Program (PAP)

Patients may be eligible to receive a
limited supply of free medication if they
are uninsured or underinsured (based on
program eligibility criteria).

Bridge Supply Program

Temporary Patient Assistance Program (TPAP)

Helping existing commercial patients access
medication should they experience change or delay
in drug coverage.

Patient Assistance Program (PAP)

Patient Assistance
Program (PAP)

Patients may be eligible to receive a limited supply of free medication if they are uninsured or underinsured (based on program eligibility criteria).

Quick Start Program

Co-Pay Assistance Program

Patients with commercial health insurance may be eligible to receive co-payment assistance from Ipsen to help reduce out-of-pocket costs for TAZVERIK.*

Quick Start Program

Co-Pay Assistance
Program

Patients with commercial health insurance
may be eligible to receive co-payment
assistance from Ipsen to help reduce
out-of-pocket costs for TAZVERIK.*

Co-Pay Assistance

Medication Support 
Nurse Program

Patients prescribed TAZVERIK who are enrolled in
IPSEN CARES can receive individualized support
services by an IPSEN CARES nurse to help them
through their treatment journey.

Bridge Supply Program

Temporary Patient Assistance Program (TPAP)

Helping existing commercial patients access medication should they experience change or delay in drug coverage.

Co-Pay Assistance

Medication Support Nurse Program

Patients prescribed TAZVERIK who are enrolled in IPSEN CARES can receive individualized support services by an IPSEN CARES nurse to help them through their treatment journey.

Note: All support is subject to eligibility criteria and program terms and conditions found on ipsencares.com. Medication Support Nurses are provided by Ipsen and do not work under the direction of the patient's healthcare provider or give medical advice. They are trained to direct patients to their provider for treatment-related advice, including referrals.

ipsencares

If you are interested in learning more about any of the support offerings mentioned, including eligibility requirements, visit ipsencares.com or contact Ipsen Cares at 1-866-435-5677, Monday through Friday, 8 AM - 8 PM ET.

*Patient Eligibility & Terms and Conditions: Patients are not eligible for copay assistance through IPSEN CARES® if they are enrolled in any state or federally funded programs for which drug prescriptions or coverage could be paid in part or in full, including, but not limited to, Medicare Part B, Medicare Part D, Medicaid, Medigap, VA, DoD, or TRICARE (collectively, “Government Programs”), or where prohibited by law. Patients receiving assistance through another assistance program or foundation, free trial, or other similar offer or program, are not eligible for the copay assistance program during the current enrollment year.

Alternative patient resources

While your healthcare team can provide support throughout your follicular lymphoma (FL) journey, there are other organizations and communities that may be able to help.

CancerCare

cancercare.org

1-800‑813‑HOPE (4673)

The Leukemia & Lymphoma Society (LLS)

LLS.org

1-800-955-4572

Lymphoma Research Foundation (LRF)

lymphoma.org

1-800-500-9976

Learn more about recommended dosing and how to take TAZVERIK.

DOSING & ADMINISTRATION

Discover downloadable patient resources.

PATIENT RESOURCES

IMPORTANT SAFETY INFORMATION AND INDICATIONS

What is the most important information I should know about TAZVERIK?

TAZVERIK can cause serious side effects, including:

  • Risk of new cancers. An increase in new (second) cancers has happened in people who were treated with TAZVERIK. Talk with your healthcare provider about your risk of developing new cancers. Your healthcare provider will monitor you for new cancers after your treatment with TAZVERIK. Tell your healthcare provider if you are more tired than usual, or have easy bruising, fever, bone pain, or paleness.

Before taking TAZVERIK, tell your healthcare provider about all of your medical conditions, including if you:

  • Are pregnant or plan to become pregnant. TAZVERIK can harm your unborn baby. Your healthcare provider will give you a pregnancy test before you start treatment with TAZVERIK. Tell your healthcare provider right away if you become pregnant or think you may be pregnant.
    • Females who are able to become pregnant should use effective non-hormonal birth control (such as condoms) during treatment and for 6 months after the final dose of TAZVERIK. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not be effective if used during treatment with TAZVERIK. Talk to your healthcare provider about birth control options that are right for you.
    • Males with female partners who are able to become pregnant should use effective birth control during treatment and for 3 months after the final dose of TAZVERIK.
  • Are breastfeeding or plan to breastfeed. It is not known if TAZVERIK passes into your breast milk. Do not breastfeed during treatment and for 1 week after the final dose of TAZVERIK.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAZVERIK may affect the way other medicines work and other medicines may affect how TAZVERIK works.

What should I avoid while taking TAZVERIK?

  • Avoid eating grapefruit or drinking grapefruit juice during treatment with TAZVERIK.
  • Avoid taking St. John’s wort during treatment with TAZVERIK.

Talk to your healthcare provider before starting any new medications, vitamins, or herbal supplements.

What are the possible side effects of TAZVERIK?

The most common side effects of TAZVERIK in people with follicular lymphoma include:

  • Tiredness
  • Cold-like symptoms (upper respiratory infection)
  • Bone and muscle pain
  • Nausea
  • Stomach (abdominal) pain

These are not all the possible side effects of TAZVERIK.

Call your doctor for medical advice about side effects. You may report side effects to Ipsen Biopharmaceuticals, Inc. at 1-855-463-5127 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

INDICATIONS

What is TAZVERIK?

TAZVERIK is a prescription medicine used to treat:

  • Adults with follicular lymphoma when the disease has come back or did not respond to treatment, whose tumors have an abnormal EZH2 gene, and who have been treated with at least two prior medicines. Your healthcare provider will perform a test to make sure TAZVERIK is right for you.
  • Adults with follicular lymphoma when the disease has come back or did not respond to treatment, who have no other satisfactory treatment options.

The approval of TAZVERIK in these patients is based on a study that measured the percentage of patients whose tumor shrank or disappeared after treatment and how long that response lasted. TAZVERIK is still being studied to confirm these benefits.

It is not known if TAZVERIK is safe and effective in children less than 16 years of age.

Please see full Prescribing Information, including Medication Guide.